Error: Could not add to watchlist. X

Candriam Equities L Biotechnology

+ Watchlist
XUJ4:GR
Berlin
505.52
EUR
20.99
4.33%
As of 15:15:04 ET on 09/03/2015.
Open
498.24
Day Range
496.58 - 522.36
Previous Close
484.53
52Wk Range
315.16 - 683.50
1 Yr Return
46.99%
YTD Return
20.43%
Open
498.24
Day Range
496.58 - 522.36
Volume
93
Previous Close
484.53
52Wk Range
315.16 - 683.50
1 Yr Return
46.99%
YTD Return
20.43%
NAV (on -)
142.75
Total Assets (m USD) (on 09/02/2015)
802.178
Inception Date
04/06/2000
Premium/Discount
-
Average 52-Week Premium
-
Fund Managers
RUDI VAN DEN EYNDE
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Expense Ratio
1.77%
3 Mo Return
-8.99%
3 Yr Return
39.61%
5 Yr Return
32.74%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 588.00 k 69.30 m 7.70
Celgene Corp 521.00 k 68.38 m 7.60
Amgen Inc 353.00 k 62.34 m 6.93
Regeneron Pharmaceuticals Inc 108.00 k 59.80 m 6.64
Biogen Inc 159.50 k 50.85 m 5.65
Alexion Pharmaceuticals Inc 170.00 k 33.56 m 3.73
Vertex Pharmaceuticals Inc 248.00 k 33.48 m 3.72
BioMarin Pharmaceutical Inc 198.00 k 28.96 m 3.22
Incyte Corp 247.00 k 25.76 m 2.86
Illumina Inc 89.00 k 19.52 m 2.17
Profile
Candriam Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.
ADDRESS
Candriam Luxembourg
136 route d'Arlon
1150 Luxembourg
PHONE
352-254-3431